genmab - FDA approves Darzalex (Daratumumab) for patients
-
Selskabsmeddelelse
DARZALEX (daratumumab) opnår godkendelse fra de amerikanske sundhedsmyndigheder til behandling af patienter, som har fået adskillige tidligere behandlinger, eller som har dobbelt-refraktær myelomatose
Det første monoklonale antistof, der godkendes til behandling af myelomatose
Forventningerne til årets resultat opjusteres for at tage højde for en milestonebetaling på USD 45 mio.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind